T.‐C. Wu

Johns Hopkins University — United States

Immunology and Microbiology · Life Sciences

73h-index18.0kcitations408works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(213), Cervical Cancer and HPV Research(122), Virus-based gene therapy research(63), Hepatitis B Virus Studies(54), Cancer Immunotherapy and Biomarkers(52)

Publications408 total

Supplementary Table S2 from Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1
2025Open Access
Supplementary Table S3 from Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1
2025Open Access
Supplementary Table S4 from Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1
2025Open Access
Supplementary Table S1 from Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1
2025Open Access
Supplementary Table S5 from Safety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1
2025Open Access
Personalizing DNA Cancer Vaccines
Journal of Personalized Medicine·2025Open Access
Update: Phase I clinical trial to assess safety, tolerability and feasibility of pNGVL4aCRTE6E7L2 HPV DNA vaccine administration via intramuscular TriGrid™ electroporation delivery system in patients with HPV16-positive high-grade cervical, vulvar or vaginal intraepithelial neoplasia
Gynecologic Oncology·2025
Safety and feasibility of intramuscular pNGVL4a-CRTE6E7L2 and TA-CIN administration for the treatment of patients with HPV16+ atypical squamous cells of unknown significance or low-grade squamous intraepithelial lesion: A phase I clinical trial
Gynecologic Oncology·2025
A randomized pilot study of HPV16 L2E7E6 fusion protein vaccination site post-treatment for HPV16+ cervical cancer
Gynecologic Oncology·2025Open Access
396P A single-arm phase II study of cabozantinib and atezolizumab in patients with recurrent or metastatic esophageal squamous cell carcinoma (R/M ESCC) who failed platinum-based chemotherapy
Annals of Oncology·2025
Generation of a spontaneous murine HPV + oral cancer model with site-specific oncogene insertion using CRISPR-SONIC
Cell & Bioscience·2025Open Access
1431-P: Sweetened Beverage Intake Is Associated with Increased Risk of Type 2 Diabetes in an Australian Population—A Longitudinal Study
Diabetes·2025
The Prognostic Role of Interferon Gamma-inducible Protein 30 in ClearCell Renal Cell Carcinoma with Immune Infiltrates
Recent Patents on Anti-Cancer Drug Discovery·2025
Quercetin attenuates cisplatin-induced fatigue through mechanisms associated with the regulation of the HPA axis and MCP-1 signaling
Frontiers in Nutrition·2025· 1 citedOpen Access
P-364. Outbreak of <i>bla-</i>OXA-48 in the eastern part of Singapore
Open Forum Infectious Diseases·2025Open Access
Trends in the Prevalence of Hpv16 and Hpv18 Over Time, by Age and Race
SSRN Electronic Journal·2025Open Access
Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methods
Cell & Bioscience·2024· 2 citedOpen Access
Electroporation-mediated novel albumin-fused Flt3L DNA delivery promotes cDC1-associated anticancer immunity
Gene Therapy·2024· 1 cited
Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens
Journal of Biomedical Science·2024· 11 citedOpen Access
Current trends in high-risk human papillomavirus types and association with age and race/ethnicity in an inner-city population
Gynecologic Oncology·2024
page 1 of 21Next →

Frequent Co-authors

Chien‐Fu Hung(33), Liangmei He(11), Morris Ling(11), Drew M. Pardoll(9), Sara I. Pai(7), Wen‐Fang Cheng(7), Cornelia L. Trimble(7), Chee‐Yin Chai(6), Keng‐Fu Hsu(5), Richard B.S. Roden(4), Andrew Yang(4), Shiwen Peng(4), Louise Ferrall(3), Raphael P. Viscidi(3), Jeremy Juang(3), Tae Woo Kim(3), Ya-Chea Tsai(3), David A. Boyd(3), Archana Monie(3), Frank Guarnieri(2)